[BXRX] YoY Quarter Result on 30-Sep-2022 [#Q3]

Stock
[BXRX] Baudax Bio, Inc.
Announcement Date
08-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -287.80%
YoY- -72.18%
Quarter Report
BXRX's Result
BXRX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 0 238 281 68 0 0 -
PBT -1,776 -29,205 -16,962 11,685 -10,315 -19,092 -37.79%
Tax 158 509 3,823 -28,609 3,909 3,954 -47.46%
NP -1,934 -29,205 -16,962 11,685 -10,315 -19,092 -36.72%
Tax Rate - - - 244.84% - - -
Total Cost 1,934 29,443 17,243 -11,617 10,315 19,092 -36.72%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 0.00 -12,271.01 -6,036.30 17,183.82 0.00 0.00 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.24 -98.70 -281.20 896.01 -1,590.84 -2,944.48 -84.77%
EPS Diluted -0.24 -98.70 -281.20 868.01 -1,590.84 -2,944.48 -84.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.